Management Team

Steven L. Morganstern, MD
EXO Founder & Visionary

Steven L. Morganstern, MD is an internationally acclaimed Urologist and surgeon, with an innovative specialization in men’s sexual health. He was on the front lines of erectile dysfunction (ED) therapeutics, both with pioneering bioidentical testosterone pellet therapy and assisting on the front lines of the launch of inflatable prosthetic implants alongside of inventor Brantley Scott, MD. He served as a leading media spokesperson and expert regarding erectile dysfunction well before others were talking about it.

He was chosen as the only private clinician to be included in the original trials for Viagra. Dr. Morganstern’s medical journey spans over four decades and includes key innovations in penis implants, prostate cancer, male hormone replacement therapy, benign prostrate problems, and HGH treatments.

Dr. Morganstern's twenty-year odyssey to develop a cure for Peyronie's Disease despite skepticism from established urology is represented by ExoSurge technology. His perseverance in discovering the secrets to curing Peyronie's disease and dedication to patient care continue to inspire us all.

Kenneth J. Carney, MD, PHARM, FACS
Co-Founder
EXO Chief Medical Officer

Following a successful 20-year career as a professor of urology at Emory University and as chief of urology at Emory's "Grady Memorial Hospital", one of the nations most famed trauma center, Dr. Carney began consulting with EXO in the development of our Peyronie's technology beginning in 2017.

Dr. Carney left Emory to join EXO full time during 2022 and his skills and leadership had an immediate impact

Dr. Carney's renown in urologic trauma has been vital to the evolution of ExoSurge technology and he now leads our group of Peyronie's clinicians.

Rayvon Reynolds
Co-Founder
EXO Chief Executive Officer


Rayvon Reynolds unearthed the hidden value in Dr. Morganstern's urologic clinical platform in 2014 and has been the driving force behind the development of ExoSurge's technology for the past seven years.
 
Previously, Miss Reynolds was co-founder and inventor of a consumer packaged goods product venture in partnership with Woolite®. She leveraged her direct experience with utility patents (Miss Reynolds has eleven patents to her name) to help guide protections for ExoSurge's IP assets.

Previously, Miss Reynolds was a recognized innovator creating modernization for ultra-high single-unit retail sales and served as president of Moby Dick Seafood Restaurants national company. Moby Dick was the nation’s fourth largest fast-seafood chain at that time.

Angela Bates, NP
EXO Clinical Director

Mrs. Bates joined Morganstern Urology as a Nurse Practitioner in 2018 and became a skilled administrator of our Peyronie's treatment paradigm and helped incubate standardized patient case evaluation and management systems for ExoSurge patients.

When she's not helping build race cars with her sons and husband, she stays focused on improvements to diagnostics and vetting of initial patient evaluations in order to speed outcomes with Peyronie's clinical care.

She is directing efforts to create a supporting treatment algorithm for future clinicians that leverages and seeks to automate our insights with Peyronie's epidemiology with our long history treating varied cases and fibrous tissue plaques.

Dan Toubiana, PA-C
EXO Director, Peyronie's Surgical Research

Dan Toubiana, PA is not only one of our most requested ExoSurge treatment providers, he's also manager for many of our reconstructive surgical procedures, directly assisting Dr. Carney.

Along with providing care for Peyronie's clinical patients, Dan is focused on a couple of new directives for the future including how ExoSurge technology can be used to improve outcomes for traditional Peyronie's surgery patients.

Scott Baker
EXO Director, Medical Sciences

Scott Baker dedicated his entire career to healthcare. Over the past seven years as we tested, refined and developed new technologies – Scott remained on the forefront of each patient’s treatment protocol and the helping revise optimal applications.
 
He leads the charge managing most of our operational technology and helping validate the sciences behind them. He also manages leverages this knowledge with his innate attention to detail into success managing logistics for our expansion directives.

John Blake
EXO Director: Market Development


John Blake is seasoned senior healthcare executive having guided marketing growth at a pair of P/E-backed medical software companies during the past decade including Intrepid USA Healthcare Services and PlayMaker CRM.

Tenaya Jones
EXO Business Manager

Miss Jones manages the business side of our flagship clinical operation in Atlanta. She's been in healthcare for over 25 years, in which 14 years were in medical education. Tenaya is AAPC certified in billing and coding and is a medical auditing specialist. She is also a Registered Medical Assistant, Phlebotomy Technician and CPR instructor.

She'd developing the flow and administration systems for collection and billing of ExoSurge technology.

Becky Battle, CMA
EXO Clinical Manager

After serving as Dr. Morganstern's personal assistant and MA, Miss Battle enjoys the distinction of being the only person to have provided curative care to over 1,000 different Peyronie's patients.

Miss Battle leverages her detailed experience treating Peyronie's patients into developing our improved clinical operating systems for future urologic clinician partners.